Recently two cancer-related CRM mutations have been discovered, namely: a highly recurrent mutation in the TERT promoter that is found in many cancer types [2–5]; and a more distally located enhancer mutation upstream of the TAL1 gene in T-cell acute lymphoblastic leukemia (T-ALL) [6]. This evidence concerns the gene TAL1 and acute lymphoblastic leukemia.